CLOs on the Move

EIS Analytics

www.eisanalytics.com

 
EIS Analytics is a Vancouver, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Weber and Weber International GmbH and Co.

Weber & Weber International GmbH & Co. is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Educational Resource Systems

Educational Resource Systems is a Red Bank, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cass Co. Human Services Coordinating Council

Cass Co. Human Services Coordinating Council is a Cassopolis, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Interactions Inc

Community Interactions Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Swarthmore, PA. To find more information about Community Interactions Inc, please visit www.communityinteractions.org

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.